AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34982842 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-based biofeedback (retraining group)
Number of subjects: 20
Study 34982842 — intervention group
Group type: COMPARATOR
Intervention: Control group (tempo-synchronized music)
Number of subjects: 20
Study 34329567 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetagliptin coadministered with metformin
Number of subjects: 34
Study 34329567 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin coadministered with cetagliptin
Number of subjects: 34
Study 35195257 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice facilitation program for primary care physicians (PCPs)
Number of subjects: 0
Study 35195257 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group A)
Number of subjects: 0
Study 32649745 — intervention group
Group type: EXPERIMENTAL
Intervention: National antimicrobial stewardship campaign
Number of subjects: 1482223
Study 35105594 — intervention group
Group type: EXPERIMENTAL
Intervention: online self-compassion for weight management (SC4WM) intervention + WW programme
Number of subjects: 240
Study 35105594 — intervention group
Group type: COMPARATOR
Intervention: WW programme only
Number of subjects: 240
Study 34099382 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 1575
Study 34099382 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1575
Study 32858791 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral‐based group therapy
Number of subjects: 300
Study 32858791 — intervention group
Group type: COMPARATOR
Intervention: No further intervention (control group)
Number of subjects: 300
Study 34878629 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 646
Study 34878629 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 646
Study 33419635 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly subcutaneous semaglutide
Number of subjects: 140
Study 33419635 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 36017685 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable Training Group (VTG)
Number of subjects: 63
Study 36017685 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable Training Group (STG)
Number of subjects: 63
Study 36017685 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 63
Study 34403626 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES (neuromuscular electrical stimulation)
Number of subjects: 9
Study 34403626 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND (standing motionless)
Number of subjects: 9
Study 34403626 — intervention group
Group type: COMPARATOR
Intervention: SIT (sitting motionless)
Number of subjects: 9
Study 34462846 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (sleeve gastrectomy or gastric bypass)
Number of subjects: 403
Study 34462846 — intervention group
Group type: COMPARATOR
Intervention: Medical weight management (control group)
Number of subjects: 403
Study 34462846 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 403
Study 34462846 — intervention group
Group type: COMPARATOR
Intervention: Medical weight management
Number of subjects: 403
Study 32139110 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of legume-based protein
Number of subjects: 100
Study 32139110 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g of legume-based protein
Number of subjects: 100
Study 32139110 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of legume-based protein
Number of subjects: 100
Study 32139110 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g of legume-based protein
Number of subjects: 100
Study 35818766 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiome composition analysis using 16S V4 amplicon next-generation sequencing.
Number of subjects: 0
Study 34924027 — intervention group
Group type: EXPERIMENTAL
Intervention: Model predicted settings
Number of subjects: 80
Study 34924027 — intervention group
Group type: COMPARATOR
Intervention: Best clinical settings
Number of subjects: 80
Study 35562805 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate ≤ 10 ng/mL
Number of subjects: 2328
Study 35562805 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate ≤ 10 ng/mL in genotype CC
Number of subjects: 2328
Study 35562805 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate ≤ 10 ng/mL in genotype CT
Number of subjects: 2328
Study 35562805 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate ≤ 10 ng/mL in genotype TT
Number of subjects: 2328
Study 35562805 — intervention group
Group type: COMPARATOR
Intervention: Comparison of decline in trend between genotypes
Number of subjects: 2328
Study 33298307 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) training and delivery
Number of subjects: 0
Study 33298307 — intervention group
Group type: COMPARATOR
Intervention: Probation services as usual (Control)
Number of subjects: 0
Study 32532275 — intervention group
Group type: EXPERIMENTAL
Intervention: UMEC 31.25 mcg
Number of subjects: 421
Study 32532275 — intervention group
Group type: EXPERIMENTAL
Intervention: UMEC 62.5 mcg
Number of subjects: 421
Study 32532275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study 34971833 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical management
Number of subjects: 0
Study 34971833 — intervention group
Group type: COMPARATOR
Intervention: Endovascular treatment
Number of subjects: 0
Study 33230010 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-TENS (2-125 Hz; highest-tolerable intensity)
Number of subjects: 258
Study 33230010 — intervention group
Group type: COMPARATOR
Intervention: Placebo-TENS
Number of subjects: 258
Study 33230010 — intervention group
Group type: COMPARATOR
Intervention: No-TENS
Number of subjects: 258
Study 33136078 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-specific circuit training (TSCT)
Number of subjects: 36
Study 33136078 — intervention group
Group type: COMPARATOR
Intervention: Global stretching, memory exercises, and education sessions (Control)
Number of subjects: 36
Study 35157994 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) plus whole brain radiotherapy (WBRT) (30 Gy in 10 fractions), NTG administered via a transdermal 36 mg patch from Monday to Friday throughout WBRT (10 days)
Number of subjects: 96
Study 35157994 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) plus whole brain radiotherapy (WBRT)
Number of subjects: 96
Study 35157994 — intervention group
Group type: COMPARATOR
Intervention: Whole brain radiotherapy (WBRT) alone
Number of subjects: 96
Study 34092489 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation programme (usual care plus 12 weeks of exercise training, pedometer, health education, and text messages)
Number of subjects: 118
Study 34092489 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation programme
Number of subjects: 118
Study 34092489 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 118
Study 32102649 — intervention group
Group type: EXPERIMENTAL
Intervention: Leadership training and coaching based on priority institutional health service improvement projects
Number of subjects: 15
Study 32102649 — intervention group
Group type: COMPARATOR
Intervention: Non-trained managers in comparison institutions
Number of subjects: 15
Study 35850159 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy facial expressions as target category
Number of subjects: 0
Study 35850159 — intervention group
Group type: EXPERIMENTAL
Intervention: Angry, neutral, and happy facial expressions presented in randomized blocks
Number of subjects: 0
Study 35850159 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy targets
Number of subjects: 0
Study 35850159 — intervention group
Group type: EXPERIMENTAL
Intervention: All target conditions
Number of subjects: 0
Study 35850159 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional targets
Number of subjects: 0
Study 35850159 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral targets
Number of subjects: 0
Study 34936265 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with suspension training
Number of subjects: 105
Study 34936265 — intervention group
Group type: COMPARATOR
Intervention: Scalp acupuncture
Number of subjects: 105
Study 34936265 — intervention group
Group type: COMPARATOR
Intervention: Suspension training
Number of subjects: 105
Study 35426776 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE1 (5 ng/kg/min)
Number of subjects: 50
Study 35426776 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE1 (5 ng/kg/min) in COVID-19 patients
Number of subjects: 50
Study 33054984 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual patient information with examples based on an apple farmer (arm I)
Number of subjects: 1068
Study 33054984 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual patient information with examples testing a treatment against worms (arm II)
Number of subjects: 1068
Study 33054984 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual patient information short version without examples (arm III)
Number of subjects: 1068
Study 33054984 — intervention group
Group type: COMPARATOR
Intervention: Standard written information (arm IV)
Number of subjects: 1068
Study 32497524 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose vaccine (3·2 × 10^3 per 0·1 mL)
Number of subjects: 120
Study 32497524 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose vaccine (3·2 × 10^4 per 1 mL)
Number of subjects: 120
Study 32497524 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vaccine (3·2 × 10^5 per 1 mL)
Number of subjects: 120
Study 32497524 — intervention group
Group type: EXPERIMENTAL
Intervention: All dose groups
Number of subjects: 120
Study 35830572 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrawound vancomycin powder (1000 mg)
Number of subjects: 980
Study 35830572 — intervention group
Group type: COMPARATOR
Intervention: Control group (no topical antibiotics)
Number of subjects: 980
Study 34939582 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH) treatment
Number of subjects: 70
Study 34939582 — intervention group
Group type: COMPARATOR
Intervention: non-rhGH treatment
Number of subjects: 70
Study 32219498 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary co-management program
Number of subjects: 3021
Study 32219498 — intervention group
Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 3021
Study 36191322 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 0
Study 36191322 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study 33559704 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 3163
Study 33559704 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 3163
Study 33559704 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin and Glimepiride
Number of subjects: 3163
Study 32306301 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 136
Study 32306301 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resisted Exercise (PRE)
Number of subjects: 136
Study 32306301 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 136
Study 34957660 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3726
Study 34957660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3726
Study 32928896 — intervention group
Group type: EXPERIMENTAL
Intervention: First hour of continuous video-electroencephalography (cEEG) graded as normal, mildly, moderately, or severely abnormal
Number of subjects: 266
Study 32928896 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal cEEG background (excluding those with seizures in the first hour)
Number of subjects: 266
Study 32928896 — intervention group
Group type: EXPERIMENTAL
Intervention: Severely abnormal cEEG background (excluding those with seizures in the first hour)
Number of subjects: 266
Study 35881154 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypohydration (HYPO)
Number of subjects: 30
Study 35881154 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study 35881154 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 34789638 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplement with whey peptides and branched-chain amino acids
Number of subjects: 20
Study 34789638 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 34205103 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling in the adductor pollicis muscle
Number of subjects: 65
Study 34205103 — intervention group
Group type: COMPARATOR
Intervention: Placebo needling
Number of subjects: 65
Study 34205103 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling in the adductor muscle
Number of subjects: 65
Study 34205103 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling in the anterior tibialis muscle
Number of subjects: 65
Study 36397087 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter sent from family doctor to parents informing them of the importance of asthma preventer medication during summer holidays.
Number of subjects: 1279
Study 36397087 — intervention group
Group type: EXPERIMENTAL
Intervention: Informing GP practices of the PLEASANT study findings with recommendations.
Number of subjects: 1279
Study 36397087 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-saving per patient over the year.
Number of subjects: 1279
Study 34265789 — intervention group
Group type: EXPERIMENTAL
Intervention: CGI VR
Number of subjects: 103
Study 34265789 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Capture VR
Number of subjects: 103
Study 34265789 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 103
Study 32485641 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% caloric restriction (CR) for two years
Number of subjects: 220
Study 32485641 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum diet (AL) for two years
Number of subjects: 220
Study 35679184 — intervention group
Group type: EXPERIMENTAL
Intervention: ENB-EBUS-GS
Number of subjects: 385
Study 35679184 — intervention group
Group type: COMPARATOR
Intervention: EBUS-GS
Number of subjects: 385
Study 33153063 — intervention group
Group type: EXPERIMENTAL
Intervention: SsObserWork
Number of subjects: 61
Study 33153063 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study 616186557 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (400 mg cefixime)
Number of subjects: 2
Study 616186557 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (400 mg cefixime)
Number of subjects: 2
Study 616186557 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 2
Study 33496831 — intervention group
Group type: EXPERIMENTAL
Intervention: Abaloparatide (ABL), 80 μg
Number of subjects: 250
Study 33496831 — intervention group
Group type: COMPARATOR
Intervention: Teriparatide (TPTD), 20 μg
Number of subjects: 250
Study 34782927 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring autograft (Auto)
Number of subjects: 50
Study 34782927 — intervention group
Group type: COMPARATOR
Intervention: Allograft (Allo)
Number of subjects: 50
Study 34782927 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 34596433 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell injection every 3 weeks
Number of subjects: 100
Study 34596433 — intervention group
Group type: COMPARATOR
Intervention: Conventional dressing
Number of subjects: 100
Study 35272209 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 61
Study 33914755 — intervention group
Group type: EXPERIMENTAL
Intervention: Grassland Ecological Compensation Policy (GECP)
Number of subjects: 449
Study 33914755 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-agricultural and animal husbandry income
Number of subjects: 449
Study 33914755 — intervention group
Group type: EXPERIMENTAL
Intervention: Herders’ age and breeding scale
Number of subjects: 449
Study 35194047 — intervention group
Group type: EXPERIMENTAL
Intervention: eTRF
Number of subjects: 90
Study 35194047 — intervention group
Group type: EXPERIMENTAL
Intervention: mTRF
Number of subjects: 90
Study 35194047 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 33144246 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy trials
Number of subjects: 120
Study 33144246 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 120
Study 32842270 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab (75 mg Q2W, with dose up titration to 150 mg Q2W at week 12 if LDL-C ≥1.81 mmol/L at week 8)
Number of subjects: 456
Study 32842270 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 456
Study 32842270 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe (10 mg daily)
Number of subjects: 456
Study 32842270 — intervention group
Group type: COMPARATOR
Intervention: Alirocumab and Ezetimibe
Number of subjects: 456
Study 35733198 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored BP-limb length based on total small bowel length (TSBL): TSBL < 500 cm, BP-limb 150 cm; TSBL 500–700 cm, BP-limb 180 cm; TSBL > 700 cm, BP-limb 210 cm.
Number of subjects: 212
Study 35733198 — intervention group
Group type: COMPARATOR
Intervention: Standard BP-limb length of 150 cm.
Number of subjects: 212
Study 35733198 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored BP-limb length based on TSBL.
Number of subjects: 212
Study 34002069 — intervention group
Group type: COMPARATOR
Intervention: Enzalutamide (PROSPER trial)
Number of subjects: 3
Study 34002069 — intervention group
Group type: COMPARATOR
Intervention: Apalutamide (SPARTAN trial)
Number of subjects: 3
Study 34002069 — intervention group
Group type: COMPARATOR
Intervention: Darolutamide (ARAMIS trial)
Number of subjects: 3
Study 35976467 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity red-light (LRL) therapy
Number of subjects: 102
Study 35976467 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation of LRL therapy
Number of subjects: 102
Study 35976467 — intervention group
Group type: COMPARATOR
Intervention: Single-focus spectacles (SFS)
Number of subjects: 102
Study 33279888 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery as a single regimen (group A)
Number of subjects: 40
Study 33279888 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery combined with intralesional corticosteroids (group B)
Number of subjects: 40
Study 33279888 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery (group A)
Number of subjects: 40
Study 33279888 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery (group A) and Cryosurgery combined with intralesional corticosteroids (group B)
Number of subjects: 40
Study 32227247 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg immediate-release, twice daily for 36 months)
Number of subjects: 336
Study 32227247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study 32227247 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 336
Study 35610566 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-coiling catheter
Number of subjects: 140
Study 35610566 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 140
Study 32761731 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month preconception lifestyle intervention
Number of subjects: 577
Study 32761731 — intervention group
Group type: COMPARATOR
Intervention: Control group (care as usual)
Number of subjects: 577
Study 35296983 — intervention group
Group type: EXPERIMENTAL
Intervention: ISOT (Improving the safety of opioid therapy)
Number of subjects: 286
Study 32272653 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure-Time Physical Activity (LTPA)
Number of subjects: 5739
Study 32272653 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behaviour
Number of subjects: 5739
Study 32272653 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet Quality (Mediterranean Diet adherence)
Number of subjects: 5739
Study 32272653 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression risk
Number of subjects: 5739
Study 32272653 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometrics and biochemical markers
Number of subjects: 5739
Study 36088374 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant and Young Child Feeding (IYCF) practices
Number of subjects: 1360
Study 36088374 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiving practices
Number of subjects: 1360
Study 34314855 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt recommending brief (low effort) cognitive and/or behavioral self-regulatory strategies
Number of subjects: 112
Study 34314855 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt recommending more effortful cognitive or mindfulness-based strategies
Number of subjects: 112
Study 34314855 — intervention group
Group type: COMPARATOR
Intervention: No intervention prompt
Number of subjects: 112
Study 32350297 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic hysterectomy
Number of subjects: 50
Study 32350297 — intervention group
Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 50
Study 35435859 — intervention group
Group type: EXPERIMENTAL
Intervention: Distant Reiki applied for 20 minutes a day for 4 consecutive days
Number of subjects: 62
Study 35435859 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 62
Study 33769463 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence in situ hybridization (FISH) on the primary tumor
Number of subjects: 305
Study 33769463 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse transcription‐polymerase chain reaction (RT‐PCR) on the primary tumor
Number of subjects: 305
Study 33769463 — intervention group
Group type: EXPERIMENTAL
Intervention: Next‐generation sequencing
Number of subjects: 305
Study 33769463 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall testing results
Number of subjects: 305